BIIB vs SEMR · P/E 21, rev $9.89B vs rev $376.8M
Biogen Inc (BIIB) versus Semrush Holdings Inc (SEMR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Semrush Holdings Inc (SEMR) is a software - application company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SEMR revenue for 2024-12-31 was $376.8M. Net income was $7.4M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. SEMR currently screens at market cap $1.81B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SEMR currently screens at market cap $1.81B.
Not investment advice. Open the BIIB and SEMR stock pages for the full models.
Not investment advice.